Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4054) 4054
Publication (236) 236
Book Review (108) 108
Magazine Article (33) 33
Book Chapter (28) 28
Trade Publication Article (13) 13
Book / eBook (11) 11
Conference Proceeding (5) 5
Newsletter (5) 5
Newspaper Article (5) 5
Data Set (3) 3
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3220) 3220
index medicus (2031) 2031
female (1618) 1618
male (1446) 1446
venous thromboembolism (1267) 1267
middle aged (1208) 1208
aged (1040) 1040
risk factors (993) 993
thromboembolism (959) 959
adult (945) 945
peripheral vascular disease (842) 842
deep-vein thrombosis (829) 829
prevention (753) 753
surgery (753) 753
venous thrombosis (753) 753
hematology (726) 726
anticoagulants - therapeutic use (710) 710
thrombosis (703) 703
pulmonary-embolism (581) 581
treatment outcome (559) 559
pulmonary embolism (524) 524
anticoagulants (511) 511
aged, 80 and over (491) 491
retrospective studies (484) 484
medicine, general & internal (452) 452
cost-benefit analysis (443) 443
molecular-weight heparin (435) 435
risk (419) 419
prophylaxis (406) 406
venous thrombosis - prevention & control (405) 405
medicine & public health (391) 391
venous thromboembolism - prevention & control (382) 382
analysis (369) 369
care and treatment (350) 350
health aspects (340) 340
deep vein thrombosis (339) 339
mortality (331) 331
risk-factors (326) 326
management (313) 313
research (313) 313
adolescent (311) 311
venous thrombosis - drug therapy (297) 297
heparin, low-molecular-weight - therapeutic use (291) 291
diagnosis (283) 283
anticoagulants - economics (282) 282
risk assessment (281) 281
complications (279) 279
prospective studies (279) 279
deep venous thrombosis (277) 277
anticoagulants - administration & dosage (273) 273
time factors (268) 268
pharmacology & pharmacy (265) 265
venous thrombosis - etiology (265) 265
heparin (263) 263
warfarin (251) 251
enoxaparin (247) 247
patients (247) 247
venous thrombosis - economics (247) 247
incidence (244) 244
cancer (242) 242
disease (236) 236
drug therapy (235) 235
young adult (235) 235
therapy (225) 225
venous thromboembolism - epidemiology (220) 220
unfractionated heparin (215) 215
quality of life (213) 213
thromboprophylaxis (213) 213
hospitals (207) 207
united states (207) 207
venous thromboembolism - etiology (206) 206
abridged index medicus (205) 205
epidemiology (205) 205
venous thrombosis - epidemiology (203) 203
anticoagulants - adverse effects (201) 201
health care sciences & services (198) 198
oncology (195) 195
prevalence (195) 195
postoperative complications - prevention & control (194) 194
medicine (191) 191
health risk assessment (190) 190
cost-effectiveness (188) 188
venous thrombosis - diagnosis (188) 188
quality-of-life (185) 185
pulmonary embolism - prevention & control (183) 183
catheterization, central venous - adverse effects (182) 182
internal medicine (179) 179
venous thrombosis - therapy (179) 179
follow-up studies (176) 176
practice guidelines as topic (176) 176
rivaroxaban (176) 176
recurrence (172) 172
studies (168) 168
heparin - therapeutic use (167) 167
medical research (167) 167
pregnancy (166) 166
metaanalysis (165) 165
venous thromboembolism - drug therapy (164) 164
usage (163) 163
cardiology (162) 162
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4041) 4041
French (23) 23
German (21) 21
Spanish (16) 16
Portuguese (8) 8
Russian (8) 8
Japanese (4) 4
Danish (3) 3
Polish (3) 3
Chinese (2) 2
Czech (2) 2
Italian (2) 2
Dutch (1) 1
Finnish (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation
by GUANELLA, R and DUCRUET, T and JOHRI, M and MIRON, M.‐J and ROUSSIN, A and DESMARAIS, S and JOYAL, F and KASSIS, J and SOLYMOSS, S and GINSBERG, J. S and LAMPING, D. L and SHRIER, I and KAHN, S. R
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 12/2011, Volume 9, Issue 12, pp. 2397 - 2405
Background: Few studies have evaluated the long‐term economic consequences of deep vein thrombosis (DVT). None of them have incorporated prospectively... 
cohort study | deep vein thrombosis | cost determinants | post‐thrombotic syndrome | economic burden | Cost determinants | Deep vein thrombosis | Economic burden | Cohort study | Post-thrombotic syndrome | VENOUS THROMBOEMBOLISM | post-thrombotic syndrome | LONG-TERM COMPLICATIONS | DISEASE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | POSTTHROMBOTIC SYNDROME | REGISTRY | Canada | Prospective Studies | Humans | Middle Aged | Health Care Rationing | Cost of Illness | Venous Thrombosis - economics | Adult | Female | Male | Aged | Pulmonary embolism | Economic aspects | Diagnosis | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Inpatient Resource Use and Cost Burden of Deep Vein Thrombosis and Pulmonary Embolism in the United States
by LaMori, Joyce C., MHS, MBA and Shoheiber, Omar, PharmD, MBA and Mody, Samir H., PharmD, MBA and Bookhart, Brahim K., MBA, MPH
Clinical Therapeutics, ISSN 0149-2918, 2015, Volume 37, Issue 1, pp. 62 - 70
Abstract Purpose Venous thromboembolism (VTE), which comprises deep vein thrombosis (DVT) and pulmonary embolism (PE), is associated with significant morbidity... 
Internal Medicine | Medical Education | length of stay | costs | deep vein thrombosis | pulmonary embolism | Pulmonary embolism | Deep vein thrombosis | Costs | Length of stay | MANAGEMENT | VENOUS THROMBOEMBOLISM | PHARMACOLOGY & PHARMACY | ECONOMIC BURDEN | Costs and Cost Analysis | Venous Thrombosis - therapy | United States | Humans | Middle Aged | Anticoagulants - economics | Cost of Illness | Venous Thrombosis - economics | Anticoagulants - therapeutic use | Continuity of Patient Care - economics | Male | Pulmonary Embolism - therapy | Inpatients | Health Care Costs | Aged, 80 and over | Adult | Female | Aged | Pulmonary Embolism - economics | Databases, Factual | Hospitalization - economics | Thromboembolism | Mortality | Hospitalization | Hospitals | Home health care
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome
by David A. MacDougall and Anthony L. Feliu and Stephen J. Boccuzzi and Jay Lin
American Journal of Health-System Pharmacy, ISSN 1079-2082, 10/2006, Volume 63, Issue 20 Supplement 6, pp. S5 - S15
Purpose. Deep-vein thrombosis (DVT) and pulmonary embolism (PE) are associated with major morbidity and mortality, with their burden often extending to... 
Economics | Pulmonary embolism | Costs | Venous thrombosis | Mortality | SURGERY | costs | POPULATION | economics | LONG-TERM COMPLICATIONS | mortality | PHARMACOLOGY & PHARMACY | THROMBOEMBOLISM | pulmonary embolism | venous thrombosis | HIP | Recurrence | Venous Thrombosis - therapy | United States | Humans | Cost of Illness | Venous Thrombosis - economics | Insurance Claim Review - economics | Male | Pulmonary Embolism - therapy | Postphlebitic Syndrome - economics | Postphlebitic Syndrome - therapy | Female | Database Management Systems - statistics & numerical data | Retrospective Studies | Managed Care Programs - economics | Pulmonary Embolism - economics | Insurance, Health, Reimbursement - economics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Estimating Quality of Life in Acute Venous Thrombosis
by Hogg, Kerstin and Kimpton, Miriam and Carrier, Marc and Coyle, Douglas and Forgie, Melissa and Wells, Philip
JAMA Internal Medicine, ISSN 2168-6106, 06/2013, Volume 173, Issue 12, pp. 1067 - 1072
IMPORTANCE Future funding for new treatments in venous thromboembolism will be guided by cost-utility analyses. There is little available information on the... 
MEDICINE, GENERAL & INTERNAL | PULMONARY-EMBOLISM | UTILITY VALUES | Venous Thrombosis - diagnosis | Acute Disease | Prospective Studies | Anticoagulants - administration & dosage | Risk Assessment | Venous Thrombosis - drug therapy | Humans | Middle Aged | Risk Factors | Hospitals, University | Venous Thrombosis - economics | Male | Anticoagulants - adverse effects | Venous Thrombosis - etiology | Venous Thrombosis - psychology | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Ontario | Cohort Studies | Outcome and process assessment (Health Care) | Care and treatment | Venous thrombosis | Analysis | Risk factors | Quality of life
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Cost‐effectiveness of additional catheter‐directed thrombolysis for deep vein thrombosis
by Enden, T and Resch, S and White, C and Wik, H. S and Kløw, N. E and Sandset, P. M
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 06/2013, Volume 11, Issue 6, pp. 1032 - 1042
Summary Background Additional treatment with catheter‐directed thrombolysis (CDT) has recently been shown to reduce post‐thrombotic syndrome (PTS). Objectives... 
thrombolytic therapy | cost‐effectiveness analysis | post‐thrombotic syndrome | venous thrombosis | anticoagulation | decision model | Cost-effectiveness analysis | Anticoagulation | Venous thrombosis | Decision model | Post-thrombotic syndrome | Thrombolytic therapy | CONTROLLED-TRIAL | ORAL RIVAROXABAN | LONG-TERM COMPLICATIONS | cost-effectiveness analysis | POSTTHROMBOTIC SYNDROME | ECONOMIC BURDEN | RECURRENT VENOUS THROMBOEMBOLISM | ANTICOAGULANT-THERAPY | post-thrombotic syndrome | PULMONARY-EMBOLISM | PERIPHERAL VASCULAR DISEASE | COMPRESSION STOCKINGS | QUALITY-OF-LIFE | HEMATOLOGY | Quality-Adjusted Life Years | Recurrence | Markov Chains | Venous Thrombosis - therapy | Humans | Probability | Venous Thrombosis - economics | Risk | Thrombolytic Therapy - economics | Models, Statistical | Catheters - economics | Anticoagulants - chemistry | Cost-Benefit Analysis | Sensitivity and Specificity | Thrombolytic Therapy - methods | Quality of Life | Blood Coagulation Disorders - complications | Thromboembolism | Medical economics | Anticoagulants (Medicine)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Reduction of Peripherally Inserted Central Catheter-Associated DVT
by Evans, R. Scott, PhD and Sharp, Jamie H., RN, VA-BC and Linford, Lorraine H., RN, BS, CNSC and Lloyd, James F., BS and Woller, Scott C., MD and Stevens, Scott M., MD and Elliott, C. Gregory, MD, FCCP and Tripp, Jacob S., PhD and Jones, Spencer S., PhD and Weaver, Lindell K., MD, FCCP
Chest, ISSN 0012-3692, 2013, Volume 143, Issue 3, pp. 627 - 633
Background As peripherally inserted central catheter (PICC) use has increased, so has the upper extremity DVT rate. PICC diameter may pose the most modifiable... 
Pulmonary/Respiratory | CONTROLLED-TRIAL | PLACEMENT | THROMBOSIS | RESPIRATORY SYSTEM | RISK | CENTRAL VENOUS CATHETERS | CARE | CRITICAL CARE MEDICINE | Length of Stay - economics | Humans | Middle Aged | Risk Factors | Venous Thrombosis - economics | Male | Equipment Design | Young Adult | Upper Extremity Deep Vein Thrombosis - epidemiology | Venous Thrombosis - epidemiology | Adolescent | Catheters, Indwelling - adverse effects | Aged, 80 and over | Adult | Female | Venous Thrombosis - prevention & control | Aged | Child | Catheterization, Central Venous - adverse effects | Catheterization, Peripheral - adverse effects | Length of Stay - statistics & numerical data | Prevention | Usage | Venous thrombosis | Research | Peripherally inserted central catheters
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Daily Hospitalization Costs in Patients with Deep Vein Thrombosis or Pulmonary Embolism Treated with Anticoagulant Therapy
by Dasta, Joseph F and Pilon, Dominic and Mody, Samir H and Lopatto, Jessica and Laliberté, François and Germain, Guillaume and Bookhart, Brahim K and Lefebvre, Patrick and Nutescu, Edith A
Thrombosis Research, ISSN 0049-3848, 2014, Volume 135, Issue 2, pp. 303 - 310
Abstract Background Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), affects about 900,000 persons in the... 
Hematology, Oncology and Palliative Medicine | Pulmonary embolism | Costs and cost analysis | Hospitalization | Venous thrombosis | Hospital costs | UNITED-STATES | EVENTS | RIVAROXABAN | PREVALENCE | LENGTH-OF-STAY | STROKE | RATES | VENOUS THROMBOEMBOLISM | REDUCTION | PERIPHERAL VASCULAR DISEASE | NONVALVULAR ATRIAL-FIBRILLATION | HEMATOLOGY | Costs and Cost Analysis | Venous Thrombosis - drug therapy | Humans | Middle Aged | Venous Thrombosis - economics | Male | Venous Thromboembolism - drug therapy | Female | Pulmonary Embolism - drug therapy | Retrospective Studies | Venous Thromboembolism - economics | Pulmonary Embolism - economics | Cohort Studies | Hospitalization - economics | Thromboembolism | Anticoagulants (Medicine)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Indications for Catheter-Directed Thrombolysis in the Management of Acute Proximal Deep Venous Thrombosis
by Patterson, Benjamin O and Hinchliffe, Robert and Loftus, Ian M and Thompson, Matt M and Holt, Peter J.E
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 04/2010, Volume 30, Issue 4, pp. 669 - 674
Deep vein thromboses (DVTs) cause significant morbidity and mortality in the general population. Oral anticoagulation therapy may reduce thrombus propagation... 
Anticoagulants | Catheter directed thrombolysis | Thrombolysis | Thrombosis | CONTROLLED-TRIAL | catheter directed thrombolysis | CLINICAL-TRIAL | ENDOVASCULAR MANAGEMENT | THROMBECTOMY | POSTTHROMBOTIC SYNDROME | ANTICOAGULATION | thrombosis | MAY-THURNER-SYNDROME | THERAPY | anticoagulants | thrombolysis | PERIPHERAL VASCULAR DISEASE | THROMBOEMBOLISM | HEMATOLOGY | ILIAC VEIN COMPRESSION | Drug Costs | Venous Valves - physiopathology | Anticoagulants - administration & dosage | Humans | Secondary Prevention | Venous Thrombosis - complications | Patient Selection | Fibrinolytic Agents - adverse effects | Time Factors | Stockings, Compression | Postthrombotic Syndrome - etiology | Acute Disease | Risk Assessment | Venous Thrombosis - drug therapy | Administration, Oral | Venous Thrombosis - economics | Thrombolytic Therapy - economics | Treatment Outcome | Venous Thrombosis - physiopathology | Catheterization, Peripheral | Evidence-Based Medicine | Health Care Costs | Thrombectomy | Fibrinolytic Agents - economics | Cost-Benefit Analysis | Quality of Life | Fibrinolytic Agents - administration & dosage | Postthrombotic Syndrome - prevention & control | Thrombolytic Therapy - adverse effects | Vascular Patency
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The value of lower-extremity duplex surveillance to detect deep vein thrombosis in trauma patients
by Bandle, Jesse and Shackford, Steven R and Kahl, Jessica E and Sise, C. Beth and Calvo, Richard Y and Shackford, Meghan C and Sise, Michael J
Journal of Trauma and Acute Care Surgery, ISSN 2163-0755, 02/2013, Volume 74, Issue 2, pp. 575 - 580
BACKGROUND: Venous duplex surveillance (VDS) is commonly used in trauma patients considered at risk for deep venous thrombosis. Economic evaluations have not... 
Deep vein thrombosis | Value | Ultrasound | Venous thromboembolic disease | Health care reform | SURGERY | deep vein thrombosis | health care reform | VENOUS THROMBOEMBOLISM | DATA-BANK | BIAS | value | ultrasound | CARE | CRITICAL CARE MEDICINE | Leg - diagnostic imaging | Humans | Middle Aged | Risk Factors | Wounds and Injuries - complications | Wounds and Injuries - diagnostic imaging | Venous Thrombosis - diagnostic imaging | Venous Thrombosis - economics | Male | Venous Thrombosis - etiology | Injury Severity Score | Ultrasonography, Doppler, Duplex - economics | Leg - blood supply | Cost-Benefit Analysis | Wounds and Injuries - economics | Female | Retrospective Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Cost-Effectiveness Analysis of Routine Venous Doppler Ultrasound for Diagnosis of Deep Venous Thrombosis at Admission to Inpatient Rehabilitation
by Pinto, Shanti M and Yassin, Mohamed and Galang, Gary
American Journal of Physical Medicine & Rehabilitation, ISSN 0894-9115, 05/2018, Volume 97, Issue 10, pp. 747 - 753
OBJECTIVE1. Identify whether timing of venous thromboembolism (VTE) diagnosis is associated with differences in patient outcomes. 2. Perform a... 
Venous Doppler Ultrasound | Inpatient Rehabilitation | Pulmonary Embolism | Venous Thromboembolism | Cost-effectiveness Analysis | Deep Venous Thrombosis | VEIN THROMBOSIS | SPORT SCIENCES | PREVENTION | TRAUMATIC BRAIN-INJURY | MODEL SYSTEMS | PULMONARY-EMBOLISM | MAJOR ORTHOPEDIC-SURGERY | SURVEILLANCE | ACUTE STROKE | REHABILITATION | SPINAL-CORD-INJURY | THROMBOEMBOLISM | Humans | Middle Aged | Patient Admission - economics | Venous Thrombosis - diagnostic imaging | Venous Thrombosis - economics | Male | Rehabilitation Centers - economics | Ultrasonography, Doppler - methods | Time Factors | Cost-Benefit Analysis | Ultrasonography, Doppler - economics | Female | Aged | Patient Transfer - statistics & numerical data | Retrospective Studies | Early Diagnosis | Pulmonary Embolism - economics | Length of Stay - statistics & numerical data | Pulmonary Embolism - diagnostic imaging | Doppler ultrasonography | Evaluation | Hospitals | Economic aspects | Rehabilitation services | Venous thrombosis | Diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK
by Jugrin, Anamaria Vera and Ustyugova, Anastasia and Urbich, Michael and Lamotte, Mark and Sunderland, Tom
Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 113, Issue 4, pp. 778 - 792
Summary The relative efficacy and safety of dabigatran etexilate and warfarin have been evaluated in two head-to-head, phase III, treatment of acute venous... 
New Technologies, Diagnostic Tools and Drugs | Economics | Anticoagulation | Venous thrombosis | Treatment | Cost-effectiveness | treatment | cost-effectiveness | THROMBOSIS | anticoagulation | RIVAROXABAN | PREVENTION | APIXABAN | ATRIAL-FIBRILLATION | STROKE | economics | RECURRENT VENOUS THROMBOEMBOLISM | PULMONARY-EMBOLISM | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | SYSTEMIC EMBOLISM | Drug Costs | Venous Thrombosis - diagnosis | Dabigatran - adverse effects | Venous Thromboembolism - mortality | Humans | Anticoagulants - economics | Warfarin - adverse effects | Warfarin - economics | Models, Economic | Dabigatran - therapeutic use | Hemorrhage - economics | Venous Thromboembolism - drug therapy | Warfarin - therapeutic use | Time Factors | Venous Thromboembolism - economics | Venous Thromboembolism - diagnosis | Quality-Adjusted Life Years | Acute Disease | Drug Administration Schedule | Venous Thrombosis - drug therapy | Kaplan-Meier Estimate | Venous Thrombosis - mortality | Venous Thrombosis - economics | Anticoagulants - therapeutic use | Treatment Outcome | United Kingdom | Anticoagulants - adverse effects | Pulmonary Embolism - mortality | Pulmonary Embolism - diagnosis | Dabigatran - economics | State Medicine - economics | Cost-Benefit Analysis | Pulmonary Embolism - drug therapy | Hemorrhage - chemically induced | Pulmonary Embolism - economics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Deep-vein thrombosis: A United States cost model for a preventable and costly adverse event
by C. E. Mahan and M. T. Holdsworth and S. M. Welch and M. Borrego and A. C. Spyropoulos
Thrombosis and Haemostasis, ISSN 0340-6245, 09/2011, Volume 106, Issue 3, pp. 405 - 415
Preventable venous thromboembolism (VTE) and “appropriate” type, dose, and duration of prophylaxis are emerging concepts. Contemporary definitions by key... 
Adverse event | Deep-vein thrombosis | preventable | Adverse drug event | cost model | Blood Coagulation, Fibrinolysis and Cellular Haemostasis | Preventable | Cost model | HOSPITALIZED-PATIENTS | adverse event | HEPARIN-INDUCED THROMBOCYTOPENIA | VENOUS THROMBOEMBOLISM PROPHYLAXIS | POSTTHROMBOTIC SYNDROME | DRUG EVENTS | DIRECT MEDICAL COSTS | MOLECULAR-WEIGHT HEPARIN | PULMONARY-EMBOLISM | deep-vein thrombosis | PERIPHERAL VASCULAR DISEASE | COMPRESSION STOCKINGS | HEMATOLOGY | UNFRACTIONATED HEPARIN | Venous Thrombosis - drug therapy | United States | Humans | Cost of Illness | Venous Thrombosis - economics | Anticoagulants - therapeutic use | Male | Venous Thrombosis - physiopathology | Models, Economic | Anticoagulants - adverse effects | Health Care Costs - trends | Health Care Costs - statistics & numerical data | Venous Thrombosis - epidemiology | Female | Disease Management
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty
by Wood, Margaret and Mantilla, Carlos B and Horlocker, Terese T and Schroeder, Darrell R and Berry, Daniel J and Brown, David L
Anesthesiology, ISSN 0003-3022, 2002, Volume 96, Issue 5, pp. 1140 - 1146
Background: There is limited information about the frequency of perioperative complications after elective primary orthopedic total hip and knee arthroplasty... 
REPLACEMENT | VEIN THROMBOSIS | PROPHYLACTIC ANTICOAGULATION | ORTHOPEDIC-SURGERY | NONCARDIAC SURGERY | 8 COMMON OPERATIONS | ASSOCIATION TASK-FORCE | ANESTHESIOLOGY | QUALITY-IMPROVEMENT-PROGRAM | SURGICAL VOLUME | PRACTICE GUIDELINES COMMITTEE | Postoperative Complications - economics | Myocardial Infarction - epidemiology | Myocardial Infarction - mortality | Age Factors | Arthroplasty, Replacement, Knee - adverse effects | Arthroplasty, Replacement, Knee - economics | Arthroplasty, Replacement, Knee - mortality | Humans | Middle Aged | Male | Postoperative Complications - mortality | Pulmonary Embolism - epidemiology | Adult | Female | Myocardial Infarction - economics | Registries | Databases, Factual | Venous Thrombosis - mortality | Venous Thrombosis - economics | Postoperative Complications - epidemiology | Arthroplasty, Replacement, Hip - adverse effects | Pulmonary Embolism - mortality | Arthroplasty, Replacement, Hip - economics | Venous Thrombosis - epidemiology | Sex Factors | Arthroplasty, Replacement, Hip - mortality | Aged | Pulmonary Embolism - economics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Catheter‐directed thrombolysis for deep venous thrombosis might be cost‐effective, but for whom?
by Perrier, A and Bounameaux, H
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 06/2013, Volume 11, Issue 6, pp. 1029 - 1031
VEIN THROMBOSIS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | POSTTHROMBOTIC SYNDROME | Venous Thrombosis - economics | Thrombolytic Therapy - economics | Catheters - economics | Venous Thrombosis - therapy | Humans | Thrombolytic Therapy - methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data
by van Leent, Merlijn W. J and Stevanovic, Jelena and Jansman, Frank G and Beinema, Maarten J and Brouwers, Jacobus R. B. J and Postma, Maarten J
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, p. e0135054
Background Vitamin-K antagonists (VKAs) present an effective anticoagulant treatment in deep venous thrombosis (DVT). However, the use of VKAs is limited... 
PREVENTION | THROMBOEMBOLISM | WARFARIN | RIVAROXABAN | ATRIAL-FIBRILLATION | ANTICOAGULATION | MULTIDISCIPLINARY SCIENCES | Health Resources - utilization | Quality-Adjusted Life Years | Venous Thrombosis - drug therapy | Antithrombins - therapeutic use | Humans | Anticoagulants - economics | Decision Support Techniques | Health Resources - economics | Venous Thrombosis - economics | Anticoagulants - therapeutic use | Dabigatran - therapeutic use | Cost Savings | Dabigatran - economics | Netherlands | Vitamin K - antagonists & inhibitors | Antithrombins - economics | Cost-Benefit Analysis | Pulmonary Embolism - drug therapy | Retrospective Studies | Pulmonary Embolism - economics | Anticoagulants (Medicine) | Venous thrombosis | Research | Drug therapy | Health aspects | Cardiac arrhythmia | Costs | Laboratories | Embolisms | Indication | Cost reduction | Antagonists | Bleeding | Utilities | Thromboembolism | Cost engineering | Monitoring | Anticoagulants | Data analysis | Stroke | Resource utilization | Sensitivity analysis | Statistical analysis | Data processing | Patients | Thrombosis | Sensitivity | Hospitals | Utilization | Pharmacoeconomics | Cost analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights